期刊文献+

白塞病眼病111例临床分析 被引量:11

A clinical analysis of ocular involvement in 111 cases of Behcet's disease
原文传递
导出
摘要 目的 分析白塞病眼部病变的临床特点,提高对该病的认识.方法 回顾性分析北京协和医院2002-2012年收治的白塞病眼病患者的临床资料.结果 白塞病眼病111例,男性患者多见,男:女为2.08∶1.白塞病发病年龄(27.6±10.8)岁,发生眼病时年龄(31.5±10.7)岁;发生眼病时白塞病的中位病程24(0,372)个月.眼部受累:85.6%的患者双眼受累,66.7%的患者视力下降,且病程中视力0.1以下占60.4%;葡萄膜炎多见,占90.10%,其中全葡萄膜炎占62.16%.男性患者出现视力下降(57例)、增殖性视网膜病变(8例)多于女性(17例;0例),白内障发生率(58.67%)、HLA-B51阳性率(14/21)高于女性(36.11%;1/9)(P <0.05),而皮肤黏膜、内脏器官受累等眼外表现男女间差异无统计学意义.患葡萄膜炎者均予糖皮质激素、免疫抑制剂治疗,77例患者视力改善,49例患者反复发作,28例(25.5%)致盲.糖皮质激素、免疫抑制剂治疗无效或反复者(19例)给予生物制剂治疗,其中12例症状好转,2例无效,5例仍反复发作.结论 白塞病眼病以男性多见,多为葡萄膜炎,且临床表现较重,并发症多,HLA-B51阳性率高.葡萄膜炎对糖皮质激素、免疫抑制剂治疗有效,但易复发,致盲率高.TNFoα拮抗剂对复发性葡萄膜炎部分有效. Objective To study the ocular manifestations in patients with Behcet's disease (BD).Methods Medical records at Peking Union Medical College Hospital from 2002 to 2012 were reviewed to identify the patients who were diagnosed as BD with ocular involvement.Results One hundred and eleven BD patients developed ocular involvement.Males were more frequently involved,and the male/female ratio was 2.08∶ 1.The age at the onset of BD and the time of ocular involvement were (27.6-± 10.8) and (31.5 ± 10.7) years,respectively.The median interval between the diagnosis of BD and ocular disease was 24 (0,372) months.Ocular involvement was bilateral in 85.6% patients.About two thirds patients (66.7%) had impaired vision,for example,visual acuity of 0.1 or less was detected in 60.4% patients.Uveitis (90.1%) was the most common findings in BD patients with ocular involvement and the most frequent type of uveitis in both sexes was panuveitis (62.16%).Vision loss,proliferative retinopathy and cataract were more common in men.There was a statistically significantly higher frequency of positive human leukocyte antigen(HLA)-B51 in the male BD with ocular involvement than in the female.All BD patients with uveitis were given systemic corticosteroid or combined immunosuppressive agents.The improvement of visual acuity was seen in 77% BD patients,but the recurrent attacks occurred in 49% patients,resulting in blindness in 25.5% of them.TNFα blockers were given to 19 recurrent uveitis patients,12 patients improved while two had no response.Conclusions The most common ocular involvement in BD was uveitis.Males were more frequently involved with a more severe disease,higher complications and positive HLA-B51 than in females.Glucocorticoids and immunosuppressants were effective to uveitis,but high rate of recurrent inflammatory ocular attacks led to high risk of blindness.TNFα blockers may improve the outcome of recurrent BD uveitis.
出处 《中华内科杂志》 CAS CSCD 北大核心 2014年第1期44-47,共4页 Chinese Journal of Internal Medicine
关键词 贝赫切特综合征 眼疾病 葡萄膜炎 Behcet's disease Eye diseases Uveitis
  • 相关文献

参考文献15

  • 1Krause L,K(o)hler AK,Altenburg A. Ocular involvement in Adamantiades-Behcet's disease in Berlin,Germany[J].{H}Graefes Archive for Clinical and Experimental Ophthalmology,2009.661-666.
  • 2Tursen U,Gurler A,Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease[J].{H}International Journal of Dermatology,2003.346-351.
  • 3Davatchi F,Shahram F,Chams-Davatchi C. Behcet's disease in Iran:analysis of 6500 cases[J].Int J Rheum Dis,2010.367-373.
  • 4Yoshida A,Kawashima H,Motoyama Y. Comparison of patients with Behcet's disease in the 1980s and 1990s[J].{H}OPHTHALMOLOGY,2004.810-815.
  • 5Elgin U,Berker N,Batman A. Incidence of secondary glaucoma in behcet disease[J].{H}Journal of Glaucoma,2004.441-444.
  • 6Tugal-Tutkun I,Onal S,Altan-Yaycioglu R. Uveitis in Behcet disease:an analysis of 880 patients[J].{H}American Journal of Ophthalmology,2004.373-380.
  • 7Zierhut M,Saal J,Pleyer U. Behcet' s disease:epidemiology and eye manifestations in German and Mediterranean patients[J].{H}German Journal of Ophthalmology,1995.246-251.
  • 8Kitaichi N,Miyazaki A,Iwata D. Ocular features of Behcet's disease:an international collaborative study[J].{H}British Journal of Ophthalmology,2007.1579-1582.
  • 9Zouboulis CC,Turnbull JR,Martus P. Univariate and multivariate analyses comparing demographic,genetic,clinical,and serological risk factors for severe Adamantiades-Behcet's Disease[J].{H}Advances in Experimental Medicine and Biology,2003.123-126.
  • 10郑文洁,赵岩,唐福林,董怡.白塞病患者中抗内皮细胞抗体的研究[J].中华内科杂志,2005,44(12):910-913. 被引量:10

二级参考文献13

  • 1董怡.贝赫切特病[A].蒋明 DavidYu 林孝义.中华风湿病学[C].北京:华夏出版社,2004.1194-1203.
  • 2Aydintug AO,Tokgo ZG,D'Cruz DP,et al.Antibodies to endothelial cells in patients with Behcet's disease.Immunol Immunopathol,1993,67:157-162.
  • 3Lelkes PI.Conference report.Endothelial cell heterogeneity and organ specificity.Endothelium,1993,1:69-70.
  • 4Salohn KV,Tonqueze LE,Nassovov EL,et al.Anti-endothelial cell antibodies in patients with various forms of vasculitis.Clin Exp Rheumatol,1996,14:163-169.
  • 5Del Papa N,Gambini D,Meroni PL.Anti-endothelial cell antibodies and autoimmune disease.Clin Rev Allergy,1994,12:275-286.
  • 6Cervera R,Navarro M,Lopez-Soto A,et al.Antibodies to endothelial cells in Behcet's disease:cell-binding heterogeneity and association with clinical activity.Ann Rheum Dis,1994,53:265-267.
  • 7Lee KH,Chung HS,Kim HS,et al.Human alpha-enolase from endothelial cell as a target antigen of anti-endothelial cell antibody in Behect's disease.Arthritis Rheum,1996,39:758-766.
  • 8Kosar A,Ozturk M,Haznedaroglu IC,et al.Hemostatic parameters in Behcet's disease:a reappraisal.Rheumatol Int,2002,22:9-15.
  • 9Praprotnik S,Blank M,Meroni PL,et al.Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells.Arthritis Rheum,2001,44:1484-1494.
  • 10International Study Group for Behcet's Disease.Criteria for diagnosis of Behcet's Disease.Lancet,1990,335:1078-1080.

共引文献9

同被引文献113

引证文献11

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部